Monopar Therapeutics director Christopher Starr sells shares worth $659k
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
Emoluments, pensions drive higher govt operating spending
KUALA LUMPUR: Higher emoluments, retirement charges and debt servicing are driving government operating expenditure 3.8 per cent higher to RM376.8 billion in 2027.
2027 Budget: Consumers, property stocks in spotlight
KUALA LUMPUR: Consumer and property stocks are set to gain from the 2027 Budget as cash handouts and housing incentives increase household spending power and support demand for homes, according to…
Hong Kong must ease listing rules to attract more angel funds and start-ups: HKEIA
Hong Kong would need to ease its listing rules and transaction requirements to attract more angel funds and become a hub for start-ups to go global, according to a leading industry body in the city.
SJPP guarantees RM123.8bil in business financing
KUALA LUMPUR: Syarikat Jaminan Pembiayaan Perniagaan Bhd (SJPP) has facilitated RM123.81 billion in financing approvals for Malaysian businesses since 2009, reflecting continued demand for funding…
Which Global Real Estate ETF Is the Better Buy: State Street’s RWO or Xtrackers’ HAUZ?
One fund calls itself global but keeps over half its money in the U.S. The other goes fully international at a fifth of the cost.